JP Morgan analyst Jessica Fye upgrades Stoke Therapeutics (NASDAQ:STOK) from Neutral to Overweight and announces $41 price target.
EXCLUSIVE: Mill City Funds $0.6M Insurance Settlement
Mill City Ventures III, Ltd (NASDAQ: MCVT) financed a paid insurance claim of $0.55 million.
What Happened? The related short-term note will likely mature in 120 days, with a payback of $0.62 million, representing an annualized return of 36.36%.
